Skip to content. | Skip to navigation

Sections
IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.

 

Clinical Newsletters

The APGI would not be possible without the support of our collaborators nationwide. If you're an APGI collaborator, keep up to date with our clinical newsletter series.

June 2012

From our humble beginnings two years ago, in March 2012 we consented our 400th patient to the APGI. This is a significant milestone and positions us very close to achieving our overall goal of 500 patients. Click here for our most recent research update.

Read More…

December 2011

We've recruited 308 patients to date, generating 1531 tumour samples. Genomic sequence analysis and mutation verification have been completed on 70 pancreatic tumour/normal exome datasets. Read our December 2011 issue for exciting updates on project milestones this Christmas.

Read More…

December 2010

In our inaugural issue, we highlight the aims and purpose of the APGI from the clinical perspective, with a spotlight on Fremantle Hospital, WA, one of our earliest inter-state collaborators to come on-board.

Read More…